In addition, a statistical analysis conducted on clinical patients (https://www.proteinatlas.org/ENSG00000136261-BZW2/pathology)14, 15, 16 showed that high expression of BZW2 is most common in urothelial cancer among a wide variety of different cancers (Figure 1). The gene discussed is BZW2; the disease is cancer.